This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Laboratorios Salvat, S.a.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sant Fost De Campsentelles, ES (2008)
- Esplugues de Lilobregat, ES (2013)
Company Filing History:
Years Active: 2008-2013
Title: Innovations of José Hidalgo Rodriguez
Introduction
José Hidalgo Rodriguez is a notable inventor based in Esplugues de Llobregat, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address various health conditions. With a total of 2 patents, his work has garnered attention in the pharmaceutical industry.
Latest Patents
One of his latest patents refers to a stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo[2.2.2]oct-3-yl ester. This invention is particularly useful as a medicament for the treatment of urinary incontinence and other diseases involving genitourinary disorders. Another significant patent involves tyrosine derivatives as PPAR-γ-modulators. These compounds, characterized by a general formula, are designed to treat or prevent conditions mediated by PPAR-γ receptors.
Career Highlights
José Hidalgo Rodriguez is currently associated with Laboratorios Salvat, S.A., where he continues to innovate and develop new pharmaceutical solutions. His expertise in medicinal chemistry has positioned him as a valuable asset in the research and development sector.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Juan Lorenzo Catena Ruiz and Isabel Masip Masip. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.
Conclusion
José Hidalgo Rodriguez exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents reflect a commitment to improving health outcomes and addressing critical medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile